Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of Certican (everolimus, rad) in the many pathways of chronic rejection.

× No keyword cloud information.

6 in total

1. Everolimus treatment downregulates renocortical cyclooxygenase-2 expression in the rat kidney.

Authors: Klaus Höcherl; Corina Hensel; Bettina Ulbricht; Bernhard K Krämer
Journal: Br J Pharmacol Date: 2005-08 Impact factor: 8.739

Review 2. Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach.

Authors: Sadia Hassan; Murtaza Najabat Ali; Bakhtawar Ghafoor
Journal: J Cardiothorac Surg Date: 2022-04-04 Impact factor: 1.637

3. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.

Authors: Piet Finckenberg; Kaija Inkinen; Juhani Ahonen; Saara Merasto; Marjut Louhelainen; Heikki Vapaatalo; Dominik Müller; Detlev Ganten; Friedrich Luft; Eero Mervaala
Journal: Am J Pathol Date: 2003-07 Impact factor: 4.307

Review 4. Clinical pharmacokinetics of everolimus.

Authors: Gabriele I Kirchner; Ivo Meier-Wiedenbach; Michael P Manns
Journal: Clin Pharmacokinet Date: 2004 Impact factor: 6.447

5. Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors.

Authors: Aneesh Srivastava; K Muruganandham; P B Vinodh; Pratipal Singh; Deepak Dubey; Rakesh Kapoor; Anant Kumar; Raj Kumar Sharma; Narayan Prasad
Journal: Int Urol Nephrol Date: 2009-06-26 Impact factor: 2.370

6. The use of everolimus in renal-transplant patients.

Authors: Julio Pascual
Journal: Int J Nephrol Renovasc Dis Date: 2009-06-02

6 in total